These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8927089)

  • 1. Screening for chlamydia to prevent pelvic inflammatory disease.
    Abter EI; Mahmud MA
    N Engl J Med; 1996 Nov; 335(20):1531; author reply 1532-3. PubMed ID: 8927089
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for chlamydia to prevent pelvic inflammatory disease.
    Sellors J; Paavonen J
    N Engl J Med; 1996 Nov; 335(20):1531-2; author reply 1532-3. PubMed ID: 8927090
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for chlamydia to prevent pelvic inflammatory disease.
    Pittrof R
    N Engl J Med; 1996 Nov; 335(20):1532; author reply 1532-3. PubMed ID: 8927092
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.
    Scholes D; Stergachis A; Heidrich FE; Andrilla H; Holmes KK; Stamm WE
    N Engl J Med; 1996 May; 334(21):1362-6. PubMed ID: 8614421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for chlamydia--a key to the prevention of pelvic inflammatory disease.
    Hillis SD; Wasserheit JN
    N Engl J Med; 1996 May; 334(21):1399-401. PubMed ID: 8614429
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.
    Gottlieb SL; Xu F; Brunham RC
    Sex Transm Dis; 2013 Feb; 40(2):97-102. PubMed ID: 23324973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
    Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Ruitenberg EN
    Ned Tijdschr Geneeskd; 1999 May; 143(19):1012. PubMed ID: 10368724
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: Chlamydia trachomatis screening: what are we trying to do?
    Peterman TA; Gottlieb SL; Berman SM
    Int J Epidemiol; 2009 Apr; 38(2):449-51. PubMed ID: 19174542
    [No Abstract]   [Full Text] [Related]  

  • 10. Chlamydia screening may reduce pelvic inflammatory disease rates.
    AIDS Patient Care STDS; 1996 Oct; 10(5):317. PubMed ID: 11361542
    [No Abstract]   [Full Text] [Related]  

  • 11. The silent epidemic of Chlamydia: what are we missing here?
    Sanfilippo JS
    J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):231-2. PubMed ID: 18794016
    [No Abstract]   [Full Text] [Related]  

  • 12. Has the effectiveness of a single chlamydia test in preventing pelvic inflammatory disease over 12 months been overestimated?
    Hay PE; Pittrof RU
    Womens Health (Lond); 2010 Sep; 6(5):627-30. PubMed ID: 20887160
    [No Abstract]   [Full Text] [Related]  

  • 13. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study.
    Ostergaard L; Andersen B; Møller JK; Olesen F
    Clin Infect Dis; 2000 Oct; 31(4):951-7. PubMed ID: 11049776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?
    Gottlieb SL; Berman SM; Low N
    J Infect Dis; 2010 Jun; 201 Suppl 2():S156-67. PubMed ID: 20470051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review.
    Risser WL; Risser JM
    Int J STD AIDS; 2007 Nov; 18(11):727-31. PubMed ID: 18005504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG; Morré SA; van den Brule AJ; Meijer CJ; Bouter LM; Boeke AJ
    Int J Epidemiol; 2004 Apr; 33(2):416-25. PubMed ID: 15082651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis.
    Aghaizu A; Atherton H; Mallinson H; Simms I; Kerry S; Oakeshott P; Hay PE
    Int J STD AIDS; 2008 Apr; 19(4):283. PubMed ID: 18482953
    [No Abstract]   [Full Text] [Related]  

  • 18. Danish health register study: a randomised trial with findings about the implementation of chlamydia screening, but not about its benefits.
    Soldan K; Berman SM
    Sex Transm Infect; 2011 Mar; 87(2):86-7. PubMed ID: 21339315
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.
    Land JA; Van Bergen JE; Morré SA; Postma MJ
    Hum Reprod Update; 2010; 16(2):189-204. PubMed ID: 19828674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic inflammatory disease in adolescents.
    Gray-Swain MR; Peipert JF
    Curr Opin Obstet Gynecol; 2006 Oct; 18(5):503-10. PubMed ID: 16932044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.